Literature DB >> 18458734

Aripiprazole in prodromal psychosis: a case report.

Balaji Bharadwaj, R P Bhargavaraman, P R Ravi, Suresh Bada Math.   

Abstract

Entities:  

Year:  2008        PMID： 18458734      PMCID： PMC2292448          DOI： 10.4088/pcc.v10n0213c

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  6 in total

Review 1.  Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research.

Authors:  Nasra Haroun; Laura Dunn; Ansar Haroun; Kristin S Cadenhead
Journal:  Schizophr Bull       Date:  2005-10-05       Impact factor: 9.306

Review 2.  Aripiprazole for schizophrenia. Systematic review.

Authors:  H G El-Sayeh; C Morganti; C E Adams
Journal:  Br J Psychiatry       Date:  2006-08       Impact factor: 9.319

3.  Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity.

Authors:  Tandy J Miller; Thomas H McGlashan; Joanna Lifshey Rosen; Lubna Somjee; Philip J Markovich; Kelly Stein; Scott W Woods
Journal:  Am J Psychiatry       Date:  2002-05       Impact factor: 18.112

4.  The PACE Clinic: identification and management of young people at "ultra" high risk of psychosis.

Authors:  Lisa J Phillips; Steven B Leicester; Lisa E O'Dwyer; Shona M Francey; John Koutsogiannis; Amal Abdel-Baki; Daniel Kelly; Susanne Jones; Christine Vay; Alison R Yung; Patrick D McGorry
Journal:  J Psychiatr Pract       Date:  2002-09       Impact factor: 1.325

5.  Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome.

Authors:  Scott W Woods; Alan Breier; Robert B Zipursky; Diana O Perkins; Jean Addington; Tandy J Miller; Keith A Hawkins; Eva Marquez; Stacy R Lindborg; Mauricio Tohen; Thomas H McGlashan
Journal:  Biol Psychiatry       Date:  2003-08-15       Impact factor: 13.382

6.  Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms.

Authors:  Patrick D McGorry; Alison R Yung; Lisa J Phillips; Hok Pan Yuen; Shona Francey; Elizabeth M Cosgrave; Dominic Germano; Jenny Bravin; Tony McDonald; Alison Blair; Stephen Adlard; Henry Jackson
Journal:  Arch Gen Psychiatry       Date:  2002-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.